Carcinoma, Hepatocellular Clinical Trials in Jinan, Shandong
3 recruitingJinan, Shandong, China
Showing 1–3 of 3 trials
Recruiting
Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma
Carcinoma, HepatocellularImmunotherapy
Qilu Hospital of Shandong University200 enrolled1 locationNCT06571396
Recruiting
Phase 2
Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
Carcinoma, Hepatocellular
Qilu Hospital of Shandong University30 enrolled1 locationNCT06454578
Recruiting
Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma
Carcinoma, Hepatocellular
Qianfoshan Hospital92 enrolled1 locationNCT06365034